Dupilumab is a biologic medication that targets interleukin-4 and interleukin-13, key drivers of type 2 inflammation. It is used to treat moderate-to-severe atopic dermatitis (eczema), asthma, chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis.
Dupilumab
Brand names: Dupixent
Dupilumab is a biologic medication that targets interleukin-4 and interleukin-13, key drivers of type 2 inflammation. It is used to treat moderate-to-severe atopic dermatitis (eczema), asthma, chronic
Ask Health.AI about DupilumabAt a Glance
- What is it?
- Dupilumab is a biologic medication that targets interleukin-4 and interleukin-13, key drivers of type 2 inflammation. It is used to treat moderate-to-
- Drug Class
- Interleukin Inhibitor (Biologic)
Overview
Ask Health.AI about Dupilumab
Get instant answers from our AI health assistant
Sources & References
- FDA Drug Label Information — fda.gov
- National Library of Medicine (DailyMed) — dailymed.nlm.nih.gov
- MedlinePlus Drug Information — medlineplus.gov
- American Pharmacists Association — pharmacist.com
- National Institutes of Health (NIH) — nih.gov
Was this helpful?